Dr. Francisco Diaz-Mitoma

Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
An Ottawa-born pharmaceutical company is teaming up with the National Research Council in a bid to develop a vaccine that will target COVID-19 as well as two other deadly coronaviruses.